Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
w7mPMqfAPSZgRjQS
Écouter
